Research and regulatory reference

FOXO4-DRI

A source-linked reference on the identity and evidence context of FOXO4-DRI. Sources checked 6 September 2026.

Source and review status

Published sources checked

Sources checked on: 6 September 2026

Qualified clinical review: Pending. This page has not been clinically reviewed.

About this source check

AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.

Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 December 2026.

Identity

FOXO4-DRI is a peptide research construct designed to disrupt FOXO4-p53 interaction.

Sources: Published 2026

A named substance and a finished product are different claims. The name does not verify formulation, concentration, purity or equivalence to material used in a study.

Research context

This is a cell-model study. It does not establish safety, selective effects or benefit in people.

Sources: Published 2026

The source reports an observation in a defined experimental setting. Translation from a cell, tissue or animal model to people requires separate human evidence and cannot be assumed from the model alone.

Evidence boundary

This entry reports the limited source context above. It does not make a personal treatment recommendation or infer a result from a different molecule, formulation, model or study population.

The appropriate conclusion is limited to the cited record, not to untested products or uses.

Published sources

  1. FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

    Published 2026. Current article record; accessed 6 September 2026.

    Supports: Cell-senescence experiments in an oxygen-glucose-deprivation model.

Change history

DateChangeClinical-review status
6 September 2026Source-linked reference publishedPending

Keep a private record

UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.